Marcio Souza is the President and Chief Executive Officer at PRAXIS PRECISION MEDICINES INC, a biopharmaceutical company focused on developing innovative therapies for central nervous system disorders. With an extensive background in the life sciences industry, Marcio has demonstrated a strong commitment to advancing medical research and improving patient outcomes. Prior to joining PRAXIS, he held several leadership positions at prominent pharmaceutical companies, where he played a key role in driving the development and commercialization of groundbreaking treatments. Throughout his career, Marcio has been recognized for his strategic vision and ability to lead cross-functional teams in the pursuit of scientific excellence. His expertise in drug development, regulatory affairs, and business development has been instrumental in guiding PRAXIS through various stages of growth and expansion. Under his leadership, the company has made significant strides in its mission to address unmet medical needs in the field of neurology, with a focus on precision medicine approaches that target specific genetic and molecular pathways. As President and CEO of PRAXIS PRECISION MEDICINES INC, Marcio Souza is responsible for overseeing the company's overall strategy, operations, and corporate development. He works closely with the board of directors, executive team, and scientific staff to ensure that PRAXIS remains at the forefront of innovation in the treatment of central nervous system disorders. Marcio's dedication to advancing the field of precision medicine, combined with his proven track record of success, positions him as a respected leader in the biopharmaceutical industry and a driving force behind PRAXIS's mission to transform the lives of patients worldwide.